Home / Resource Library / PROSPECTIVE VALIDATION OF END OF TREATMENT CTDNA-MRD BY PHASED-SEQ IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIALPROSPECTIVE VALIDATION OF END OF TREATMENT CTDNA-MRD BY PHASED-SEQ IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL EHA 2025